Home LiteratureArticle Details
PMID: 15699381 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center.

Neurology ·Vol. 64 ·No. 3 ·2005-02-08 ·Pages 494-500

Honig LS, Kukull W, Mayeux R

Abstract

Epidemiologic studies have implicated cerebrovascular disease and its antecedents as risk factors for Alzheimer disease (AD). Cerebral atherosclerosis or strokes may increase the deposition of neuritic plaques or the formation of neurofibrillary tangles. Alternatively, they may simply hasten the age at onset of disease, or increase the severity of disease symptoms. This investigation examined the association between cerebrovascular disease and the pathologic manifestations of AD in an autopsy series. This was a cross-sectional study using data from the United States National Alzheimer's Coordinating Center database. The primary analysis included 1,054 individuals with clinical information and semiquantitative neuropathologic measurements: 921 had AD as the primary neuropathologic diagnosis and 133 were considered neuropathologically normal. Overall, 9% of the individuals had clinical history of stroke during life, but 33% had evidence of cerebral infarcts at postmortem. There was no association between neuritic plaques or neurofibrillary tangles, the primary neuropathologic manifestations of AD, with either clinical history of stroke or the presence of cerebral infarcts at postmortem. The authors did find a higher frequency of neuritic plaques and neurofibrillary tangles with increased amyloid angiopathy. Neither plaques nor tangles were associated with small vessel cerebrovascular disease, arteriosclerosis. However, the presence of large-vessel cerebrovascular disease, or atherosclerosis, was strongly associated with an increased frequency of neuritic plaques. Atherosclerotic cerebrovascular disease may have a role in the pathogenesis of Alzheimer disease, because of a strong association with frequent neuritic plaques.

MeSH Terms
Age of Onset Aged Aged, 80 and over Alzheimer Disease/epidemiology,etiology,genetics,pathology Apolipoprotein E4 Apolipoproteins E/genetics Cerebral Amyloid Angiopathy/complications,epidemiology,pathology Cerebral Infarction/complications,epidemiology,pathology Comorbidity Cross-Sectional Studies Databases, Factual Dementia, Vascular/epidemiology,etiology,pathology Female Humans Intracranial Arteriosclerosis/complications,epidemiology,pathology Male Neurofibrillary Tangles Plaque, Amyloid Risk Factors United States/epidemiology
Chemicals
Apolipoprotein E4 Apolipoproteins E
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Honig Lawrence S
Taub Institute for Research on Alzheimer's Disease and the Aging Brain, the Gertrude H. Sergievsky Center, and the Department of Neurology, Columbia University College of Physicians & Surgeons, New York, NY 10032, USA. lh456@columbia.edu
Kukull Walter
Mayeux Richard
Article Info
Journal
Neurology
Abbr.
Neurology
ISSN
1526-632X
Published
2005-02-08
Pages
494-500
Language
English
Region
United States
NLM ID
0401060
Subset
IM
Grants
NIA NIH HHS · U01 AG016976 · United States
NIA NIH HHS · AG16976 · United States
NIA NIH HHS · P50-AG 08702 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com